A novel GPER antagonist protects against the formation of estrogen-induced cholesterol gallstones in female mice [Research Articles]
In conclusion, CIMBA treatment protects against the formation of estrogen-induced cholesterol gallstones by inhibiting the GPER signaling pathway in female mice. CIMBA may thus be a new agent for effectively treating cholesterol gallstone disease in women.
Source: The Journal of Lipid Research - Category: Lipidology Authors: DeLeon, C., Wang, H. H., Gunn, J., Wilhelm, M., Cole, A., Arnett, S., Wang, D. Q.-H., Arnatt, C. K. Tags: Research Articles Source Type: research
More News: Calcium | Cholesterol | Diets | Epidemiology | Estradiol | Gallstones | Genetics | Lipidology | Nutrition | Study | Women